1
|
Tabibian S, Shams M, Naderi M, Dorgalaleh A. Prenatal diagnosis in rare bleeding disorders-An unresolved issue? Int J Lab Hematol 2018; 40:241-250. [PMID: 29476647 DOI: 10.1111/ijlh.12789] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2017] [Accepted: 01/11/2018] [Indexed: 11/30/2022]
Abstract
Intracranial haemorrhage (ICH) is the most dreadful complication, and the main cause of death among patients with rare bleeding disorders (RBD) and prenatal diagnosis (PND) is a preventative lifesaving program. A total of 39 PNDs were reported in the literature through a search on PubMed, EMBASE, SCOPUS and Web of Science databases, most often for congenital factor (F) XIII and FVII deficiencies and rarely in FX, FV deficiencies and afibrinogenemia. The main cause to request a PND is ICH and related morbidity and mortality. Different molecular methods including direct sequencing and linkage analysis as well as polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) for a specific mutation are the most common used methods for PND, while factor assay and combination of molecular and factor assay also were used. In this research, 7 severely affected foetuses were identified during PND including 3 foetuses with FXIII deficiency, 3 with FVII deficiency and 1 with FX deficiency. Out of these 7 cases, intrauterine ICH occurred in 1 case with FXIII deficiency, 1 was electively aborted and 1 case with severe FVII deficiency received intrauterine factor transfusion. Postdelivery ICH was reported for 1 patient with severe FVII deficiency within the first month of life. All other pregnancies were uneventful.
Collapse
Affiliation(s)
- S Tabibian
- Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - M Shams
- Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.,Department of Medical Laboratory, Faculty of Paramedical Sciences, Babol University of Medical Sciences, Babol, Iran
| | - M Naderi
- Genetic Research Center in Non-Communicable Disease, Zahedan University of Medical sciences, Zahedan, Iran
| | - A Dorgalaleh
- Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
2
|
Dorgalaleh A, Tabibian SH, Safa M, Shams M, Naderi M. Minimal factor XIII activity level to prevent major spontaneous bleeds: comment. J Thromb Haemost 2017; 15:2279-2280. [PMID: 28871658 DOI: 10.1111/jth.13841] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2017] [Indexed: 11/26/2022]
Affiliation(s)
- A Dorgalaleh
- Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - S H Tabibian
- Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - M Safa
- Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - M Shams
- Department of Laboratory Sciences, Paramedical Faculty, Babol University of Medical Sciences, Babol, Iran
| | - M Naderi
- Department of Pediatrics Hematology & Oncology, Ali Ebn-e Abitaleb Hospital Research Center for Children and Adolescents Health [RCCAH], Zahedan University of Medical Sciences, Zahedan, Iran
| |
Collapse
|
3
|
Dorgalaleh A, Tabibian S, Bamedi T, Tamaddon GH, Naderi M, Varmaghani B, Boustani H, Dadashizadeh G. Molecular genetic analysis of ten unrelated Iranian patients with congenital factor XIII deficiency. Int J Lab Hematol 2016; 39:e33-e36. [PMID: 28013530 DOI: 10.1111/ijlh.12606] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- A Dorgalaleh
- Departments of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - S Tabibian
- Departments of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - T Bamedi
- Department of hematoloparasitology, Iranshahr University of Medical Sciences, Iranshahr, Iran
| | - G H Tamaddon
- Department of Hematology and Blood Transfusion, School of Allied Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
| | - M Naderi
- Department of Pediatrics Hematology & Oncology, Ali Ebn-e Abitaleb Hospital Research Center For Children And Adolescents Health [RCCAH], Zahedan University of Medical Sciences, Zahedan, Iran
| | - B Varmaghani
- Departments of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - H Boustani
- Departments of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - G Dadashizadeh
- Department of Hematology and Blood Transfusion, Medicine School, Mashhad University of Medical Sciences, Mashhad, Iran
| |
Collapse
|
4
|
Dorgalaleh A, Farshi Y, Alizadeh SH, Naderi M, Tabibian SH, Kazemi A, Hosseini S. Challenges in implementation of ISTH diagnostic algorithm for diagnosis and classification of factor XIII deficiency in Iran. J Thromb Haemost 2015; 13:1735-6. [PMID: 26099358 DOI: 10.1111/jth.13037] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2015] [Accepted: 05/29/2015] [Indexed: 11/29/2022]
Affiliation(s)
- A Dorgalaleh
- Department of Hematology and Blood Transfusion, Iran University of Medical Sciences, Tehran, Iran
| | - Y Farshi
- Department of Hematology and Blood Transfusion, Tehran University of Medical Sciences, Tehran, Iran
| | - S H Alizadeh
- Department of Hematology and Blood Transfusion, Tehran University of Medical Sciences, Tehran, Iran
| | - M Naderi
- Department of Pediatrics Hematology & Oncology, Ali Ebn-e Abitaleb Hospital Research Center for Children and Adolescents Health [RCCAH], Zahedan University of Medical Sciences, Zahedan, Iran
| | - S H Tabibian
- Department of Hematology and Blood Transfusion, Tehran University of Medical Sciences, Tehran, Iran
| | - A Kazemi
- Department of Hematology and Blood Transfusion, Iran University of Medical Sciences, Tehran, Iran
| | - S Hosseini
- Department of Hematology and Blood Transfusion, Iran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
5
|
Kazemi A, Nadri M, Dorgalaleh A, Alizadeh S, Tabibian S, Taregh B. C0105: Plasminogen Activator Inhibitor-1 Polymorphism is Not Associated with Central Nervous System Bleeding in Pediatric Patients with Factor XIII Deficiency. Thromb Res 2014. [DOI: 10.1016/s0049-3848(14)50253-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
6
|
Hosseeini S, Ansari S, Kalantar E, Sabzechian M, Alibeik A, Dorgalaleh A. A fetal hemolytic anemia in a child with cytomegalovirus infection. Iran J Ped Hematol Oncol 2014; 4:78-83. [PMID: 25002930 PMCID: PMC4083205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Received: 01/02/2013] [Accepted: 03/20/2014] [Indexed: 11/15/2022]
Abstract
BACKGROUND Autoimmune hemolytic anemia is a hematologic disorder that is rarely observed in infants and young children. Most of the cases are associated with viral or bacterial infections. In some cases, AIHA can be characterized by a chronic course and an unsatisfactory control of hemolysis, thus requiring prolonged immunosuppressive therapy. CASE REPORT Especially in children younger than 2 years of age, the clinical course of the disease may show either resistance to steroids or dependence on high-dose steroids. We report here an infant fatal autoimmune. CONCLUSION This case suggests that investigation for the presence of CMV infection in infantile AIHA should be considered. Severe hemolysis is rare but could be a potentially life-threatening complication of CMV infection described mostly in immune compromised adults and children.
Collapse
Affiliation(s)
- S Hosseeini
- Aliasghar Hospital, Iran University of Medical Sciences, Tehran, Iran
- Gholhak Laboratory, Shariaty Street, Tehran, Iran
| | - Sh Ansari
- Aliasghar Hospital, Iran University of Medical Sciences, Tehran, Iran
| | - E Kalantar
- Immunology Department, Iran University of Medical Sciences, Tehran, Iran
| | - M Sabzechian
- Aliasghar Hospital, Iran University of Medical Sciences, Tehran, Iran
| | - A Alibeik
- Aliasghar Hospital, Iran University of Medical Sciences, Tehran, Iran
| | - A Dorgalaleh
- hematology and blood transfusion Department, Allied Medical School, Tehran Unversity of Medical Sciences, Tehran, Iran
| |
Collapse
|
7
|
Naderi M, Dorgalaleh A, Alizadeh S, Kashani Khatib Z, Tabibian S, Kazemi A, Dargahi H, Bamedi T. Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency. Haemophilia 2013; 20:e89-92. [PMID: 24354489 DOI: 10.1111/hae.12287] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/22/2013] [Indexed: 11/30/2022]
Affiliation(s)
- M Naderi
- Ali Ebn-e Abitaleb Hospital Research Center for Adolescents Health, Zahedan University of Medical Sciences, Zahedan, Iran
| | | | | | | | | | | | | | | |
Collapse
|
8
|
Naderi M, Dorgalaleh A, Tabibian S, Alizadeh S, Eshghi P, Solaimani G. Current understanding in diagnosis and management of factor XIII deficiency. Iran J Ped Hematol Oncol 2013; 3:164-72. [PMID: 24575291 PMCID: PMC3915454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/29/2013] [Accepted: 10/28/2013] [Indexed: 11/19/2022]
Abstract
Factor XIII or "fibrin-stabilizing factor," is a transglutaminase circulates in the blood circulation as a hetero tetramer with two catalytic A subunits and two carrier B subunits. This important coagulation factor has a crucial role in clotting cascade and produces strong covalent bonds between soluble formed fibrin monomers during coagulation. This stable cross linked fibrin strands are resistanttodegradationby thefibrinolyticsystem that enablesthe bodyto stoppotential bleeding episodes. In the absence or severe decrease of factor XIII, although the clot is formed, but is rapidly degraded by the fibrinolytic system, and delayed bleedingoccurs.Factor XIII deficiency is an extremely rare bleeding disorder with estimated incidence of 1/2-3000, 000 in the general population. Presumptive diagnosis of factor XIII deficiency was by clot solubility test in 5M urea or 1% monochloroacetic acid environments. In patients with abnormal screening clot solubility test, the disease can be confirmedbymore specifictestssuch as quantitative factor XIII activity assay andFXIIIAgassay.After diagnosis of disease all patients with severe factor XIII deficiency(<1 U/dl) shouldreceive prophylactic substitution therapywith fresh frozen plasma (FFP) and cryoprecipitate as traditional choices or purified concentrateof blood coagulation factor XIII (Fibrogammin P) inorder to control severe and life-threatening clinical complications of factor XIII deficiency.
Collapse
Affiliation(s)
- M Naderi
- Genetic Researcher Center in Non-Communicable Disease, Zahedan University of Medical sciences
| | - A Dorgalaleh
- Hematology Department, Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
| | - Sh Tabibian
- Hematology Department, Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
| | - Sh Alizadeh
- Hematology Department, Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
| | - P Eshghi
- Pediatric Congenital Hematologic Disorders Research Center, Zahedan University of Medical sciences
| | - Gh Solaimani
- Genetic Researcher Center in Non-Communicable Disease, Zahedan University of Medical sciences
| |
Collapse
|
9
|
Dorgalaleh A, Mahmoodi M, Varmaghani B, Kiani node F, Saeeidi Kia O, Alizadeh S, Tabibian S, Bamedi T, Momeni M, Abbasian S, Kashani Khatib Z. Effect of thyroid dysfunctions on blood cell count and red blood cell indice. Iran J Ped Hematol Oncol 2013; 3:73-7. [PMID: 24575274 PMCID: PMC3915449] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/20/2012] [Accepted: 03/10/2013] [Indexed: 11/17/2022]
Abstract
BACKGROUND Thyroid hormones have a crucial role in metabolism and proliferation of blood cells. Thyroid dysfunction induces different effects on blood cells such as anemia, erythrocytosis leukopenia, thrombocytopenia, and in rare cases causes' pancytopenia. It also alter RBC indices include MCV, MCH, MCHC and RDW. Thus this study attempted to evaluate effect of hypo & hyperthyroidism on blood cell count and RBC indices. MATERIALS AND METHODS This study performed on 102 patients with hypothyroid (14.1 years), 84 with hyperthyroid (15.6 years) and 118 healthy individuals (15.2 years) as control group. Initially patients TSH level of patients was determined by ELISA method, and then according to TSH ranges (0.3-5.5µIU/mL) patients were divided into two Hyperthyroidism (TSH<0.3µIU/mL) and hypothyroidism (TSH>5.5µIU/mL) groups. Then, complete blood count was measured by cell counter. Finally, obtained results were analyzed by SPSS software. RESULTS Analyzes of obtained data revealed statistically significant difference between two groups of patients in RBC count, MCH, MCHC, RDW, HB and HCT(P-value<0.05), but the difference was not significant for WBC and PLT counts and MCV (P-value>0.05). CONCLUSION In case of patients with unknown hematological dysfunctions, must be evaluated for thyroid hormones.
Collapse
Affiliation(s)
- A Dorgalaleh
- Hematology Department Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
| | - M Mahmoodi
- Pars pathobiology laboratory, Minoodasht, Golestan, Iran
| | - B Varmaghani
- Hematology Department Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
| | - F Kiani node
- Hematology Department Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
| | - O Saeeidi Kia
- Medical Laboratory Sciences Department Allied Medical School, Zahedan University of Medical Sciences, Zahedan, Iran
| | - Sh Alizadeh
- Hematology Department Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
| | - Sh Tabibian
- Hematology Department Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
| | - T Bamedi
- Parasitology Department Allied Medical School, Zahedan University of Medical Sciences, Zahedan, Iran
| | - M Momeni
- Imam Ali hospital, Sistan and Baluchistan, Chahbahar, Iran
| | - S Abbasian
- Hematology Department Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
| | - Z Kashani Khatib
- Hematology Department Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
10
|
Naderi M, Eshghi P, Saneei Moghaddam E, Alizadeh SH, Dorgalaleh A, Younesi MR, Khateb ZK. Safety of human blood products in rare bleeding disorders in southeast of Iran. Haemophilia 2012; 19:e90-2. [DOI: 10.1111/hae.12068] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/05/2012] [Indexed: 12/01/2022]
Affiliation(s)
- M. Naderi
- Department of Pediatrics Hematology & Oncology; Ali Ebn-e Abitaleb Hospital Research Center for Children And Adolescents Health [RCCAH]; Zahedan University of Medical Sciences; Zahedan; Iran
| | - P. Eshghi
- Departement of Pediatric Hematology & Oncology; Shahid Beheshti University of Medical Sciences; Tehran; Iran
| | - E. Saneei Moghaddam
- Blood transfusion Research center; High Institute for Research and Education in Transfusion Medicine and Zahedan Regional Educational Blood Transfusion Center; Zahedan; Iran
| | | | - A. Dorgalaleh
- Hematology Department; Allied Medical School; Tehran University of Medical Sciences; Tehran; Iran
| | - M. R. Younesi
- Hematology Department; Allied Medical School; Tehran University of Medical Sciences; Tehran; Iran
| | - Z. K. Khateb
- Student scientific research center (SSRC); Allied Medical School; Tehran University of Medical Sciences; Tehran; Iran
| |
Collapse
|